Loading...
01/10 19:55
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed picture: strong shareholder returns through dividends and share repurchases, growth in smoke-free products, and strategic goals focused on future growth. However, the negative impact of the ITC orders, impairment charges, and declining cigarette volumes due to economic pressures and illicit market challenges offset these positives. The Q&A reveals consumer pressure from inflation and management's cautious approach to the discount segment and tariffs. Overall, the sentiment is balanced, suggesting minimal stock price movement in the short term.
Adjusted Operating Companies Income (OCI) - Smokable Products $X (2.7% increase year-over-year) due to robust net price realization of 10.8%.
Adjusted OCI Margins - Smokable Products 64.4% (up 4.2 percentage points year-over-year) attributed to strong pricing.
Domestic Cigarette Volumes - Smokable Products Declined by 13.7% (12% adjusted for calendar differences) due to growth of illicit e-vapor products and economic pressures on consumers.
Discount Cigarette Segment Share Grew by 1.8 share points, indicating consumers seeking price relief.
Marlboro Retail Share - Premium Segment 59.3% (up 0.1 share point year-over-year) demonstrating strong brand loyalty.
Total Adjusted OCI - Oral Tobacco Products Over $400 million with strong margins at 69.2%, slightly down year-over-year.
Total Shipment Volume - Oral Tobacco Products Decreased by 5%, with ON! growth offset by lower MST volumes.
Adjusted Equity Earnings from ABI $146 million (down 11.5% year-over-year) due to lower ownership interest.
Dividends Paid Approximately $1.7 billion in the first quarter.
Share Repurchases 5.7 million shares repurchased in March.
Remaining Share Repurchase Authorization $674 million remaining under the current program.
Total Debt to EBITDA Ratio 2.1 times, in line with the target of approximately 2 times.
Noncash Impairment Charge $873 million due to ITC orders affecting Enjoy.
ON! Growth: Oral nicotine pouches drove an estimated 10% increase in oral tobacco industry volume over the past six months. ON! grew its share of the oral tobacco category to 8.8%, an increase of 1.8 share points versus the prior year.
NJOY Product Pipeline: Altria plans to refine and strengthen its e vapor product portfolio following the exit of EnjoyAce from the market, focusing on innovative e vapor products.
E Vapor Market Growth: The e vapor category included more than 20 million vapers, up over 2.6 million versus a year ago, with disposable vapers increasing by an estimated $4 million to approximately $14 million.
Illicit E Vapor Products: Illicit e vapor products now represent more than 60% of the category, prompting Altria to advocate for regulatory reforms and enhanced enforcement.
Smokable Products Segment: The Smokable Products segment grew adjusted operating companies income by 2.7%, supported by robust net price realization of 10.8%.
Adjusted OCI: Total adjusted OCI for the Oral Tobacco Products segment was over $400 million in the first quarter.
NJOY Acquisition: Altria is combining the capabilities gained from the NJOY acquisition to broaden its pipeline of innovative e vapor products.
Regulatory Advocacy: Altria is actively engaging with Congress to advocate for quicker product authorizations and stronger enforcement against illicit e vapor products.
Economic Pressures on Consumers: Smokers are facing economic pressure due to inflation exceeding wage growth, particularly affecting low-income consumers. This has led to a decline in domestic cigarette volumes as consumers seek price relief.
Illicit E-Vapor Market: The e-vapor category is significantly impacted by illicit products, which now represent over 60% of the market. This has led to a decline in legitimate e-vapor sales and poses a challenge for regulatory compliance.
Regulatory Challenges: Altria is advocating for regulatory reforms to expedite product authorizations and enhance enforcement against illicit e-vapor products. The company is actively engaging with Congress and state AGs to address these issues.
Impact of Tariffs: Increased tariffs on imports, particularly from China, may affect costs and consumer behavior. The company is monitoring the situation closely, as tariffs could impact disposable income and purchasing behavior.
NJOY Acquisition Challenges: The ITC's exclusion order and cease and desist orders have forced Enjoy to discontinue certain products, limiting FDA-authorized choices for consumers and impacting market share.
Market Share Pressures: Marlboro's retail share declined by one percentage point, and the discount cigarette segment grew, indicating a shift in consumer purchasing behavior due to economic pressures.
Impairment Charges: Altria recorded a noncash impairment charge of $873 million related to the NJOY acquisition, reflecting challenges in the e-vapor market.
ON! Brand Growth: ON! continued its momentum at retail, expanding its share of the oral tobacco category to 8.8%, an increase of 1.8 share points versus the prior year.
E-Vapor Strategy: Altria is focused on advocating for regulatory reforms to accelerate product authorizations and enhance enforcement against illicit actors in the e-vapor market.
NJOY Acquisition: Altria plans to combine the capabilities gained from the NJOY acquisition with an evolved view on today’s vapers to broaden NJOY’s pipeline of innovative e-vapor products.
Optimize and Accelerate Initiative: The guidance range includes the reinvestment of anticipated cost savings related to the previously announced Optimize and Accelerate initiative.
2025 Full Year Adjusted EPS Guidance: Expected to deliver full year adjusted diluted EPS in a range of $5.3 to $5.45, representing a growth rate of 2% to 5% from a base of $5.19 in 2024.
Impact of Tariffs: Guidance contemplates limited impact of increased tariffs on costs and potential impacts on consumers based on presently available information.
Consumer Behavior Monitoring: Altria will continue to closely monitor the state of consumers, including how the economic impact of tariffs could affect their purchasing behaviors.
Dividends Paid: Approximately $1,700,000,000 in dividends were paid in the first quarter.
Share Repurchase: 5,700,000 shares were repurchased in March.
Remaining Share Repurchase Authorization: $674,000,000 remaining under the current share repurchase program, expected to be completed by the end of the year.
The earnings call presents a mixed but overall positive picture. Strong financial metrics include an increase in oral tobacco margins and cigarette retail share. Despite a decline in shipment volume, the growth in the on! product line and increased retail share are positives. The Q&A reveals confidence in future performance and strategic initiatives like international expansion and product differentiation. Although there are concerns about deceleration in earnings growth and competitive pressures, the raised EPS guidance and share repurchase plan are positive signals. Given these factors, a positive stock price movement is likely.
The earnings call presents a mixed outlook. While there are positive aspects like growth in the on! brand and strategic initiatives, there are also concerns such as the NJOY ACE market re-entry and challenges from illicit vapes. The guidance is cautious with a modest EPS growth projection. The Q&A highlights uncertainties, particularly regarding competitive challenges and regulatory issues. Overall, the sentiment is balanced, with no strong positive or negative indicators.
The earnings call presents a mixed picture: while there are positive aspects such as increased EPS and shareholder returns, there are significant concerns about regulatory challenges, particularly with the NJOY ACE withdrawal and impairment charge. The Q&A reveals management's confidence in pricing strategies but acknowledges consumer pressures and market uncertainties. The overall sentiment is balanced by these opposing factors, leading to a neutral prediction for stock price movement.
The earnings call presents a mixed picture: strong shareholder returns through dividends and share repurchases, growth in smoke-free products, and strategic goals focused on future growth. However, the negative impact of the ITC orders, impairment charges, and declining cigarette volumes due to economic pressures and illicit market challenges offset these positives. The Q&A reveals consumer pressure from inflation and management's cautious approach to the discount segment and tariffs. Overall, the sentiment is balanced, suggesting minimal stock price movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
